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Result: Frequencies of malignant arrhythmia were significantly higher in Group 2 than in
Group 1 (62% vs 35%, p<0.05). Pericardial effusion and cardiac rupture were observed
more frequently in Group 2 than in Group 1 (62% vs 11%, P<0.001; 15% vs 0%,
p<0.001, respectively). All patients with cardiac rupture were observed in Group 2,
including one patient with subepicardial aneurysm and three with oozing rupture. Con-
gestive heart failure was observed more frequently in Group 2 than in Group 1 (46% vs
9%, p<0.001).
Conclusions: Even patients achieving TIMI grade 3 flow after PCI were often complicated
by malignant arrhythmia, pericardial effusion, and congestive heart failure if their CFV
patterns indicated severe microvascular injury. Thus, evaluation of CFV patterns immedi-
ately after PCI is clinically useful since they serve as predictors of the presence or
absence of complications, and in order to classify the severity of the patient’s condition in
the early stage.
1157-44 Are High Doses of Intracoronary Adenosine an 
Alternative to Standard Intravenous Adenosine for the 
Assessment of Fractional Flow Reserve?
Volker Klauss, Gianni Casella, Johannes Rieber, Viktoria Seelig, Markus Leibig, Andreas 
König, Karl Theisen, Uwe Siebert, Thomas Schiele, Med. Poliklinik - Innenstadt, 
University of Munich, Munich, Germany, Harvard Center for Risk Analysis, Harvard 
School of Public Health, Boston, MA
Background: Fractional flow reserve (FFR) is a measure of coronary stenosis severity
based on pressure measurements obtained at maximal hyperemia. Therefore, achieving
maximal vasodilatation is a prerequisite for determining FFR. All validation studies were
performed with intravenous adenosine (Ado-iv). However, compared to intracoronary
adenosine (Ado-ic), Ado-iv is more expensive, more time consuming and possibly asso-
ciated with more side effects. The present study was designed to compare high doses of
Ado-ic with Ado-iv.
Methods: 57 lesions (LAD,n=27; LCx, n=15; RCA, n=15) were studied in 54 pts. FFR was
assessed five times in every pt, with 4 bolus injections of Ado-ic (60, 90, 120 and 150 µg)
and standard Ado-iv (140µg/kg/min) in a randomized changing sequence.
Results: No adverse events occurred with Ado-ic injections into the LCA. Transient AV-
blocks were observed with Ado-ic into the RCA (4/15). With Ado-iv, minor side effects
(angina, dyspnoe) were noted in 21/54 pts (39%). Hemodynamics were not different.
Mean FFR was 0.79, 0.80, 0.78, 0.77 with 60 µg, 90 µg, 120 µg, 150 µg Ado-ic and 0.76
with Ado-iv. Focusing on the lowest absolute FFR value in every patient this was
achieved in 2% with the 60 µg dose, in 8% with 90 µg, in 20% with 120 µg, in 16% with
150 µg and in 62% with the intravenous application. With 60 µg of adenosine, 32% of
FFR values were below the cut-off point of 0.75. Higher doses increased this percentage
to 40%, 41%, 41%, and 46% for 90 µg, 120 µg, 150 µg, and the iv administration, respec-
tively.
Conclusions: This study suggests a dose-response relationship for intracoronary doses
higher than 60 µg. The administration of high intracoronary adenosine boluses is safe
and associated with fewer systemic side effects than standard intravenous adenosine.
However, intravenous adenosine with 140 µg/kg/min produced a more pronounced hype-
remia compared to intracoronary adenosine in the majority of patients and should thus
be the preferred mode of application for the assessment of FFR.
1157-45 Significant Increase in the Thrombolysis in Myocardial 
Infarction Frame Count When the Coronary Artery 
Stenosis Is More Than 75 Percent Reflects Significant 
Flow Abnormalities at This Degree of Stenosis in 
Chronically Diseased Coronary Arteries
Kunadian Vijayalakshmi, James A. Hall, Robert A. Wright, Mark A. de Belder, The James 
Cook University Hospital, Middlesbrough, United Kingdom
The TFC has been proposed as a quantitative method to assess coronary blood flow.
This has been studied in the setting of an acute coronary syndrome. The effect of the
TFC on chronically diseased coronary arteries when film acquisition is made at 12.5f/s is
not available.
Aim: To determine the impact of coronary artery stenosis severity on the TFC in chroni-
cally stenosed coronary arteries when films are acquired at 12.5 f/s.
Methods: Coronary angiography was performed using 6F Judkins diagnostic catheters
after 200 micrograms of intracoronary nitrate acquired at 12.5 f/s. Analysis was per-
formed to obtain the mean TFC and the corrected TFC for <50% stenosis (group A), 50-
75% stenosis (group B) and >75% stenosis (group C). Results were corrected to give val-
ues equivalent to an acquisition rate of 30f/s. TIMI frame counting was performed by an
independent observer using the Philips Inturis Suite viewer R2.2.
Results are shown in tables 1. There was statistically significant difference in the TFC
between groups C & A and groups C & B: p=<0.01 and p=<0.01 for RCA; p=<0.01 and
<0.01 for CX; and p=<0.01 and <0.01 for LAD respectively. There was no significant dif-
ference in the TFC between groups A & B (p=0.1, 1.0 and 0.4 for RCA, CX and LAD
respectively).
Conclusion: We have demonstrated that there was a significant increase in the TFC
when the coronary artery stenosis was more than 75% reflecting significant flow abnor-
malities at this degree of stenosis in chronically diseased coronary arteries. 
1157-46 Hemodynamic Impairment of Intermediate Stenoses in 
Saphenous Vein Coronary Artery Bypass Grafts and 
Recipient Vessels: Evaluation by Doppler Flow Velocity
Liesbeth P. Salm, Wouter Jukema, Susan E. Langerak, Hubert W. Vliegen, Paul 
Steendijk, Aeilko H. Zwinderman, Jeroen J. Bax, Hildo J. Lamb, Albert De Roos, Ernst E. 
Van der Wall, Leiden University Medical Center, Leiden, The Netherlands, Interuniversity 
Cardiology Institute of the Netherlands, Utrecht, The Netherlands
Background: Coronary flow velocity reserve (CFVR) measured with the Doppler flow
wire is commonly used to evaluate hemodynamic impairment of intermediate coronary
artery stenoses. The purpose of the present study was to investigate the diagnostic value
of Doppler flow velocity measurements in the evaluation of intermediate stenoses in
saphenous vein coronary artery bypass grafts and recipient vessels.
Methods: A total of 56 patients with a history of bypass surgery underwent coronary
angiography with Doppler velocity measurements before and after adenosine administra-
tion due to recurrent chest pain. Velocity was digitized to compute baseline and stress
average peak velocity (APV; cm/s), systolic peak velocity (SPV; cm/s), diastolic peak
velocity (DPV; cm/s), diastolic-to-systolic velocity ratio (DSVR) and CFVR. Quantitative
coronary arteriography was performed to objectively determine stenosis severity.
Results: Sixty-seven grafts had a luminal stenosis severity <50% (n=47) or 50-75%
(n=20). To determine diagnostic performances of each parameter in the identification of
intermediate stenoses (50-75%) in single grafts significant areas-under-the-curve in
receiver operating characteristic analysis were found for DPVbaseline, APVstress, SPVstress
and DPVstress (p<0.05). In sequential grafts significant areas-under-the-curve were dem-
onstrated for APVstress and DPVstress (p<0.05). CFVR did not show significance in sepa-
rating grafts with stenoses <50% and 50-75% for single or sequential grafts. In
multivariate analysis sensitivity/specificity/diagnostic accuracy of velocity parameters for
the identification of intermediate stenoses were 92%/72%/78% for single grafts and
100%/73%/82% for sequential grafts.
Conclusion: Doppler velocity accurately identifies intermediate stenoses by differentiat-
ing between <50% and 50-75% stenosis in both single and sequential vein grafts and
recipient vessels. Doppler velocity measurements have additional diagnostic value in
evaluating intermediate stenoses in vein grafts and recipient vessels.
1157-47 Coronary Flow Velocity Pattern Immediately After 
Percutaneous Coronary Intervention in Patients With 
Acute Myocardial Infarction Can Predict Myocardial 
Viability Assessed by Thallium Scintigraphy at Six 
Months
Koichi Tamita, Takashi Akasaka, Atsushi Yamamuro, Minako Katayama, Shunichirou Kaji, 
Kazuaki Tanabe, Kunihiko Nagai, Tomoko Tani, Shigefumi Morioka, Tsutomu Takagi, 
Kobe General Hospital, Kobe, Japan, Kawasaki Medical School, Kurashiki, Japan
Background: Some studies have shown that the no-reflow phenomenon after coronary
reflow implies the absence of residual infarct-zone viability. Furthermore, it has been
reported that the coronary flow velocity (CFV) pattern of no-reflow in patients with reper-
fused acute myocardial infarction (AMI) is characterized by the appearance of early sys-
tolic retrograde flow and short diastolic deceleration time (DDT). However, the
relationship between CFV pattern and residual myocardial viability has not been dis-
cussed. The aim of this prospective study was to examine whether the CFV pattern may
predict myocardial viability at the late stage.
Methods: The study population consisted of 113 consecutive patients with a first anterior
AMI successfully treated with percutaneous coronary intervention (<50% residual steno-
sis). We examined the CFV pattern immediately after coronary intervention using a Dop-
Table 1
TFC – Diseased RCA in elective coronary angiography [Mean ± SD]
RCA Group A <50% Group B 50-75% Group C >75%
Number 41 22 18
Reference diameter 3.3 ± 1.1 3.4 ± 1 3 ± 0.8
TFC 8 ± 2 9.4 ± 5 31 ± 21
cTFC 19 ± 4 22.8 ± 13 75 ± 52
TFC – Diseased CX in elective coronary angiography [Mean ± SD]
CX Group A <50% Group B 50-75% Group C >75%
Number 35 21 23
Reference diameter 3.5 ± 0.8 3.3 ± 0.7 2.8 ± 0.5
TFC 12 ± 4 12.3 ± 3.9 20 ± 11
cTFC 29 ± 9 30 ± 9 49 ± 25
TFC – Diseased LAD in elective coronary angiography [Mean ± SD]
LAD Group <50% Group B 50-75% Group C >75%
Number 39 31 34
Reference diameter 3.3 ± 0.7 3.4 ± 0.8 3 ± 0.7
TFC 17 ± 8 16.5 ± 7 24 ± 12
cTFC 28 ± 12 26 ± 11 38 ± 19
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pler guidewire. Patients were divided into two groups based on myocardial viability
assessed by single-photon emission computed tomographic thallium-201 imaging 6
months after the infarction; 81 patients with viable myocardium and 32 patients with non-
viable myocardium. Redistribution patterns or residual maximal myocardial activity >50%
are indices of tissue viability.
Results: Coronary flow velocity variables showed significantly higher systolic peak veloc-
ity (8±20 vs -31±23 cm/s; p=0.0001) and longer DDT (722±196 vs 312±157 ms;
p=0.0001) in viable myocardial group compared with nonviable myocardial group. The
optimal cutoff values to predict viable myocardium was 0 cm/s for systolic peak velocity
and 600ms for DDT (sensitivity=0.85, specificity=0.94 and sensitivity=0.93, specific-
ity=0.91, respectively).
Conclusion: These data suggest that the CFV pattern is an accurate predictor of the
presence or absence of residual myocardial viability at the late stage in patients with
anterior AMI.
1157-48 Reduced Shear Stress and Large Shear Stress Gradient 
Cause Coronary Aneurysm and Thrombus Formation in 
Children With Kawasaki Disease
Ei Ikegami, Ryuji Fukazawa, Mituhiro Kamisago, Miharu Hajikano, Miki Watanabe, Yohko 
Uchikoba, Yasuhiro Katube, Shunichi Ogawa, Nippon Medical School, Tokyo, Japan
We tested whether reduced shear stress (SS) and large shear stress gradient could be
caused coronary artery aneurysm (AN) formation at coronary branching site and throm-
bus formation in AN in patients with Kawasaki disease (KD). 139 children (2y - 16y) who
had coronary abnormality revealed by 2-D echo were subjected. All patients had different
sized AN without any significant stenosis in proximal and distal portion of AN and were
divided into four groups by the maximum diameter of AN; Group S: < 1.5-fold the diame-
ter of the adjacent normal-looking vessel, n=34, Group M:1.5 </= to < 4.0-fold, n=31,
Group L: </= 4.0-hold, n=29, Group N: normal-looking vessels by CAG, n=45. All patients
had Aspirin and / or Warfarin. The averaged peak velocity (APV) was measured at the
middle of ANs in groups L, M and S, at the branching site of segment 5-6-11 in group N,
and at the normal-looking proximal lesion of AN in all 4 groups. SS was calculated by the
simplified formula as: shear stress = 4µAPV/(R/2), where µ is blood viscosity, R is maxi-
mum inner diameter of AN or coronary vessel. SS gradient was calculated by the formula
as: SS gradient = SS at normal-looking lesion / SS at AN or coronary branching site.
Also, CAG and IVUS were performed for detection of thrombus and localization of
ANs.Results:* p < 0.05 vs. groups M, S. SS in normal-looking vessels were 26.6 ± 3.1
Conclusions: Reduced shear stress and large shear stress gradient may play a critical
role of giant aneurysm and thrombus formation intra coronary aneurysms in Kawasaki
disease.
1157-49 Physiologic and Anatomical Evaluation Prior to and 
After Stent Implantation in Small Coronary Vessels: 
Final Results of PHANTOM Trial
Marco A. Costa, Manel Sabate, Rodolfo Staico, Fernando Alfonso, Paul Gilmore, Brett 
Sasseen, Martin Zenni, Seixas Ana Cristina, J Eduardo Sousa, Carlos Macaya, 
Theodore Bass, University of Florida Shands Jacksonville, Jacksonville, FL, Hospital 
Clinico San Carlos, Madrid, Spain
Background: Long-term outcomes after PCI of small coronary artery disease remain
suboptimal, but there is no diagnostic tool available to define (in)appropriateness of PCI
in this setting. This prospective multicenter study investigates the role of intravascular
ultrasound (IVUS), quantitative coronary angiography (QCA) and fractional flow reserve
(FFR) in patients with small coronary arteries.
Methods: Sixty patients with small coronary arteries (reference diameter <2.8mm) and
coronary stenoses between 40-70% were included. A 0.014-in pressure guide wire
(Wave Wire) was used for FFR measurements after 2 minutes of IV infusion of adenosine
(140 µg/kg/min). Volumetric 3D-IVUS and angiography data were analyzed in an inde-
pendent core laboratory. PCI was deferred if FFR >0.75. Optimal stenting was defined by
IVUS (minimal lumen area (MLA) instent >80% of reference MLA). Clinical follow-up was
scheduled at 6 and 12 months.
Results: Mean age was 62.4±10y, 40% had diabetes and 84% had HTN. There were no
procedure complications. Mean RD (reference diameter) was 2.1mm. Sixty percent of the
patients had normal FFR (<0.75). Seventy percent of patients with a CSA obstruction
>70% by IVUS had an FFR<0.75, while 100% with CSA obstruction >75% had FFR
<0.75. Angiographic MLD was not correlated with FFR. Forty-four percent had post-
stenting FFR<0.90 in spite of optimal IVUS result. Fifty six patients completed at least 6
month follow-up (25 completed 12-month). Among patients who did not undergo index
PCI because of an FFR<0.75 (n=27 out of 56 with follow-up), none required follow-up
revascularization. There were 5 repeat PCI in the cohort of patients initially treated with
PCI (n=23). Complete follow-up data will be presented. Conclusion: The majority of
intermediate lesions in small vessels may not require PCI. There is a poor correlation
between physiological and anatomical parameters in patients with small vessel disease.
Deferring PCI based on FFR>0.75 appears to be safe in patients moderate stenosis in
small coronary vessels. Considering the high incidence of restenosis, FFR represents a
valuable tool to define the appropriateness of PCI in small vessels.
1157-50 Hyperinsulinemia Is Associated With Coronary 
Endothelial Dysfunction in Obese and Nondiabetic 
Patients
Hideki Okui, Shuichi Hamasaki, Takashi Yoshitama, Sanemasa Ishida, Akiko Yoshikawa, 
Tetsuro Kataoka, Koji Orihara, Masakazu Ogawa, Tsuyoshi Fukudome, Naoya Oketani, 
Keishi Saihara, Takuro Shinsato, Shinichi Minagoe, Chuwa Tei, Kagoshima University, 
Kagoshima, Japan
Background: The American Heart Association (AHA) has recently classified obesity as a
modifiable risk factor for coronary heart disease. Therefore, we evaluated the impact of
obesity on insulin resistance and coronary endothelial function in overweight patients
with normal or mild coronary artery disease. Methods: A total of 32 consecutive non-dia-
betic patients with normal or mildly diseased coronary arteries at angiography underwent
coronary vascular reactivity evaluation using intracoronary administration of papaverine,
acetylcholine and nitroglycerin using a Doppler guidewire. Patients were divided into two
groups based on body mass index (BMI): Group 1, patients with a BMI<25 (n = 19, nor-
mal weight); and Group 2, patients with a BMI>25 (n = 13, overweight). The level of fast-
ing immunoreactive insulin (FIRI) and fasting blood glucose (FBS) were measured in
each subject. Homeostasis model assessment (HOMA-R) was used as an indicator of
insulin resistance. Results: FIRI and HOMA-R in Group 2 were significantly greater than
those in Group 1 (4.4±2.7 vs. 14.5±7.4 µU/ml, p<0.01; 1.02±0.62 vs. 3.52±1.77, p<0.01,
respectively), whereas FBS was similar when comparing the two groups (95±11 vs.
98±13 mg/dl). The percent change in coronary blood flow and coronary artery diameter
induced by acetylcholine in Group 2 had a significant negative correlation with both
HOMA-R and FIRI (HOMA-R:r=-0.69, p<0.01; r=-0.64, p<0.02,FIRI: r=-0.69, p<0.01; r=-
0.72, p<0.01,respectively) but displayed no significant correlation in Group 1. Conclu-
sions: Obesity with hyperinsulinemia caused by increased insulin resistance is associ-
ated with coronary endothelial dysfunction in non-diabetic patients.
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1158-51 A Novel Antirestenosis Effect of Paclitaxel-Eluting 
Stents
Arturo G. Touchard, Mark Ungs, Bradley Poff, James Barry, Mary E. Russell, Greg 
Wilson, Robert S. Schwartz, Minnesota Cardiovascular Research Institute, Minneapolis, 
MN, Minneapolis Heart Institute, Minneapolis, MN
Background: Coronary stenting is a known, potent stimulator of adventitial angiogene-
sis.These post stent angiogenesis may help neointimal growth and maintenance. Cell
migration and proliferation blockage are two known mechanism of Paclitaxel limiting
neointimal hiperplasia. Paclitaxel is a known angiogenesis inhibitor in other tissues, like
tumors, nonentheless this effect on coronary arteries has not been yet studied. We thus
examined adventitial neovascularization in porcine coronary arteries following paclitaxel
eluting stent implant and compared them with control stents.
Methods: Forty-three stented arteries, 26 paclitaxel stents (1ug/mm2) and 17 controls
were examined blindly. Adventitial vessels (vasa vasorum) were identified as arterial
structures with endothelial cells surrounding a lumen, with or without erythrocytes.
Adventitial vessel density was determined by manual counting using a curved geometric
shape 400x50 microns placed in the adventitia, bordering the external elastic lamina. Inti-
mal thickness was measured from the back of each strut to the lumen and calculated an
average for each artery.
Results: Paclitaxel-stented arteries showed a marked decrease in adventitial vessels
compared with control stented vessels (1.5+1.2 versus 3.1 + 2.2 vessels/20,000 sq
microns, p<0.003). There was no statistical difference in minimum intima thickness
between the treated and control groups in this mild injury model (paclitaxel: 308.9 + 57.3,
controls: 284.9 + 59.0 microns, p>0.5).
Conclusions: Paclitaxel elution from stents is associated with markedly decreased
adventitial angiogenesis. In addition to its anti migratory and antiproliferative effects,
paclitaxel may prevent neointimal growth by preventing adventitial vasa vasorum, limiting
oxygen and nutrient supply to the neointima. If true, this opens novel therapeutic strate-
gies for limiting neointimal hyperplasia.
1158-52 Proteomic Profiling of Restenotic Lesions Unveils 
Increased Expression of Structural Proteins That Are 
Inhibited by Intramural Delivery of Rapamycin 
Ute Buerke, Markus Guckenbiehl, Ursula Müller-Werdan, Karl Werdan, Michael Buerke, 
Johannes Gutenberg University, Halle, Germany
Restenosis is the major limiting factor of balloon angioplasty.Identifying genes that regu-
late neointima formation is ongoing, facilitated by cDNA array profiling of the arterial wall.
This study utilizes proteomic profiling to identify gene products involved in arterial remod-
eling that occurs as a consequence of restenosis. We specifically identified proteins
inhibited by rapamycin since this drug is being used clinically for its anti-restenotic prop-
erties.
Intramural infusion of rapamycin or its vehicle was delivered through a balloon catheter
directly into the vessel wall during angioplasty. After 3 weeks, proteomic profiles of arte-
rial wall segments were obtained. On average, 485 protein spots were consistently
SS in AN or branching site SS gradient thrombus
L 6.8+/-3.3* 4.1+/-1.1* 24/29*
M 21.8+/-5.3 1.2+/-0.5 2/31
S 25.6+/-4.6 1.1+/-0.4 0/34
N 9.7+/-2.9* 3.0+/-1.5* 0/45
